Treatment of chronic myeloid leukemia in the imatinib era: perspective from a developing country.
about
Imatinib for treating newly diagnosed chronic myeloid leukemia patientsImatinib for treating patients with chronic myelogeneous leukemiaSummary of the published Indian data on chronic myeloid leukemiaThe treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, Ahmedabad.Phase distribution of chronic myeloid leukemia in BangladeshEffect of imatinib therapy with and without turmeric powder on nitric oxide levels in chronic myeloid leukemia.Changing trends in clinico-morphological profile of chronic myeloid leukemia-our experience.Influence of late treatment on how chronic myeloid leukemia responds to imatinib.Chronic myeloid leukemia treatment with Imatinib: An experience from a private tertiary care hospital.Nonadherence to imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia.Geographic and income variations in age at diagnosis and incidence of chronic myeloid leukemia.Imatinib mesylate in early chronic phase chronic myeloid leukemia: Experience from a developing country.Chronic myeloid leukemia patients in Tunisia: epidemiology and outcome in the imatinib era (a multicentric experience).Assessment of quality of life with imatinib mesylate as first-line treatment in chronic phase-chronic myeloid leukemia.Pregnancy outcomes in patients with chronic myeloid leukemia treated with imatinib mesylate: short report from a developing country.
P2860
Q24186877-16995B2D-9492-4766-8813-FAD094E8CCA4Q24241730-C54CF17E-559D-4D62-8BEE-CB2BE542FB7AQ28075574-1387B3E4-EB31-4581-B2C3-2B582F31279BQ30754830-763232D3-9C2C-4D08-9BAA-818E1E663A67Q33559182-EED585B5-FD8C-4344-8004-FFC26E5C8669Q34631681-21AD7714-55F9-409B-94CA-30C8FCA0F53AQ36588069-B813168C-AC44-4A7D-82D4-381C39B034AFQ37308623-0216FC1E-79D7-4468-BC2D-0DA078EBF9F9Q37517604-8AEEB0E4-2D0D-4E6B-ACD5-0C02FA44566BQ39754589-0652D2EC-B0A9-41CE-AE5F-7507B856441BQ40345134-09B11874-7FEB-455B-965F-0A82399B3DD2Q46735715-37BF6933-786C-4365-B0B6-D4B3032F4F3FQ47203365-68886870-F73E-485C-9282-55D25314FCDAQ48681328-BEBBF1B3-73DC-4762-B472-530599360122Q51184825-A71A242F-6CE9-4696-9890-4EBB2A4DBB2E
P2860
Treatment of chronic myeloid leukemia in the imatinib era: perspective from a developing country.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Treatment of chronic myeloid l ...... ive from a developing country.
@en
Treatment of chronic myeloid l ...... ive from a developing country.
@nl
type
label
Treatment of chronic myeloid l ...... ive from a developing country.
@en
Treatment of chronic myeloid l ...... ive from a developing country.
@nl
prefLabel
Treatment of chronic myeloid l ...... ive from a developing country.
@en
Treatment of chronic myeloid l ...... ive from a developing country.
@nl
P2093
P356
P1433
P1476
Treatment of chronic myeloid l ...... ive from a developing country.
@en
P2093
Javaid Iqbal
Mohammad Akram
Sarah Saeed
P304
P356
10.1002/CNCR.22498
P407
P577
2007-03-01T00:00:00Z